Distributor inventory | Tablet
Glimepiride 1 mg + Metformin hydrochloride 500 mg (sustained/extended-release) + Pioglitazone 15 mg
Type 2 diabetes mellitus (adult) to improve blood sugar control when diet and exercise alone or fewer medicines are not adequate
Glimepiride (a sulfonylurea) increases insulin release from the pancreas. Metformin reduces glucose production in the liver and improves insulin sensitivity. Pioglitazone improves insulin sensitivity in muscle and fat by activating PPAR-γ, helping the body use insulin better.
Take exactly as prescribed by your doctor. Usually taken once daily with/after food (preferably with breakfast) to reduce stomach upset; swallow tablet whole (do not crush/chew, especially if sustained/extended-release). Monitor blood glucose regularly.
Common side effects of TRIOPIL 1 TAB 10S may include:
May cause low blood sugar—risk increases with missed meals, alcohol, excess exercise, or with other antidiabetics; keep glucose/sugar source available. Metformin can rarely cause lactic acidosis—risk higher in kidney disease, dehydration, severe infection, heavy alcohol use; dose adjustment/avoid in renal impairment. Pioglitazone may cause fluid retention and can worsen heart failure; avoid/use with caution in heart failure and monitor for swelling/shortness of breath. Periodic monitoring of blood sugar, kidney function, liver function and weight is advised. Inform doctor before surgery or contrast dye procedures (metformin may need temporary stoppage).
